arrow
S

Saikat Santra

University College London
H指数:37
被引数:4,832

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

From Neonatal Encephalopathy to Adult Survival: Revisiting the Natural History of D-Bifunctional Protein Deficiency in a Multicentre International Case Series

从新生儿脑病到成人存活:多中心国际病例系列中重新审视D-双功能蛋白缺乏的自然史

2025-12-090
PRE
Acute-onset axonal neuropathy following infection in children with biallelic RCC1 variants: a case series

儿童中biallelic RCC1变异者在感染后出现的急性起病轴索神经病:一个病例系列

2025-07-160
OAAI
Long-term efficacy and safety of arimoclomol in Niemann-Pick disease type C: Final results of the phase 2/3 NPC-002 48-month open-label extension trial

Arimoclomol在尼曼-皮克病C型中的长期疗效与安全性:NPC-002 48个月开放标签扩展试验2/3期的最终结果

2025-07-070
PRE
Natural history of epilepsy in argininosuccinic aciduria provides new insights into pathophysiology: A retrospective international study
2023-04-105
OAAI
MaP NATURAL HISTORY STUDY: CLINICAL AND BIOMARKER FINDINGS IN PROPIONIC ACIDEMIA
2023-03-010
PRE
MaP NATURAL HISTORY STUDY: CLINICAL AND BIOMARKER FINDINGS IN METHYLMALONIC ACIDEMIA DUE TO MUT DEFICIENCY
2023-03-010
PRE
Clinical disease characteristics of patients with Niemann-Pick Disease Type C: findings from the International Niemann-Pick Disease Registry (INPDR)
2022-02-1424
OAAI
Persistent effect of arimoclomol in patients with Niemann-Pick disease type C: 24-month results from an open-label extension of a pivotal phase 2/3 study

arimoclomol对C型niemann-pick病患者的持续作用: 关键2/3期研究的开放标签扩展的24个月结果

2022-02-010
PRE
Clinical disease progression and biomarkers in Niemann-Pick disease type C: a prospective cohort study (vol 15, 328, 2020)
2021-06-011
OAAI
Persistent effect of arimoclomol in patients with Nuemann-Pick disease type C: 12-month results from an open-label extension of a pivotal phase 2/3 study
2021-02-010
PREAI
Clinical disease progression and biomarkers in Niemann-Pick disease type C: a prospective cohort study
2020-11-2315
OAAI
Efficacy and safety of arimoclomol in patients with Niemann-Pick disease type C: Results from a double-blind, randomized placebo controlled trial with a novel treatment
2020-02-011
PREAI